Lilly Announces CFO Anat Ashkenazi Resignation and Launches Succession Search

Gelonghui June 5 | U.S. pharmaceutical company Eli Lilly and Company stated that its Chief Financial Officer, Anat Ashkenazi, has resigned. The company is actively seeking her successor from both internal and external candidates.